A 12-month-old male with diagnosis of hepatoblastoma (Figure 1).
Hepatoblastoma is the most common malignant tumor of the liver in the pediatric population, affecting mostly young boys age < 3 years and accounting for 75% of primary liver tumors in childhood. Diagnosis is usually at a late stage. Nevertheless, the introduction of chemotherapy with cisplatin and doxorubicin has changed the treatment success of hepatoblastoma substantially, and despite a large tumor mass at presentation, a combined surgical and chemotherapeutic approach has yielded a 5-year survival rateof approximately 80%.